Antimicrobial susceptibility of Streptococcus sp. to quinupristin-dalfopristin in China.

Yuan Hai You; Hai Bin Wang; Xiao Xia Tao; Yan Yan Song; Fan Liang Meng; Xiao Mei Yan; Feng Ji Luo; Jian Zhong Zhang

Return

Antimicrobial susceptibility of Streptococcus sp. to quinupristin-dalfopristin in China.

Author: Yuan Hai YOU ^{1
,

2} ; Hai Bin WANG ³ ; Xiao Xia TAO ¹ ; Yan Yan SONG ³ ; Fan Liang MENG ¹ ; Xiao Mei YAN ¹ ; Feng Ji LUO ³ ; Jian Zhong ZHANG ¹ ;
Author Information

1. State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
2. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, Zhejiang, China.
3. Laboratory of Microbiology, Chaoyang District Center for Disease Control and Prevention, Beijing 100021, China.
Publication Type:Letter
MeSH: Anti-Bacterial Agents; pharmacology; China; Microbial Sensitivity Tests; Streptococcus; drug effects; Virginiamycin; pharmacology
From: Biomedical and Environmental Sciences 2014;27(5):388-390
CountryChina
Language:English
Abstract: This study aimed to determine the in vitro activity of quinupristin-alfopristin against Streptococcus sp. isolated in China. This agent is not yet available for clinical use, but it has been tested against a high proportion of resistant Staphylococcus aureus strains. A total of 156 streptococcal isolates, which were recovered from various geographic areas and diseases, were tested using the Etest (AB Biodisk, Solna, Sweden). Quinupristin-alfopristin showed excellent activity against all of the tested streptococci isolates. These results provide useful data for the clinical use of quinupristin-alfopristin in China.